• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?

作者信息

Khan Muhammad Ali, Cholankeril George, Howden Colin W

机构信息

Department of Gastroenterology and Hepatology, University of Tennessee Health Science Center, Memphis, Tennessee.

出版信息

Gastroenterology. 2017 Jun;152(8):2076. doi: 10.1053/j.gastro.2016.10.050. Epub 2017 May 4.

DOI:10.1053/j.gastro.2016.10.050
PMID:28478154
Abstract
摘要

相似文献

1
Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?质子泵抑制剂与肝硬化患者肝性脑病的可能发生：真实关联还是残余混杂？
Gastroenterology. 2017 Jun;152(8):2076. doi: 10.1053/j.gastro.2016.10.050. Epub 2017 May 4.
2
Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport.质子泵抑制剂的使用通过调节血脑屏障药物转运引发肝硬化患者的脑病。
Gastroenterology. 2017 Jun;152(8):2077. doi: 10.1053/j.gastro.2016.10.049. Epub 2017 May 4.
3
Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.肝硬化患者使用质子泵抑制剂的风险：请仔细研读适应证。
Dig Dis Sci. 2024 Jan;69(1):7-9. doi: 10.1007/s10620-023-08153-3. Epub 2023 Nov 15.
4
Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast.质子泵抑制剂对肝硬化患者的自发性细菌性腹膜炎和肝性脑病构成威胁吗？别急着下结论。
Hepatology. 2017 Jan;65(1):393. doi: 10.1002/hep.28858. Epub 2016 Nov 15.
5
Letter to the Editor: Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.致编辑的信：质子泵抑制剂与肝硬化患者的轻微及显性肝性脑病相关，并增加死亡率。
Hepatology. 2019 Aug;70(2):760-761. doi: 10.1002/hep.30641.
6
Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis.质子泵抑制剂与肝硬化住院期间肝性脑病风险的关联
United European Gastroenterol J. 2018 Oct;6(8):1179-1187. doi: 10.1177/2050640618773564. Epub 2018 Apr 23.
7
Letter to the Editor: Proton Pump Inhibitors in Cirrhosis: A Marker of Morbid Conditions or a Cause of Mortality?致编辑的信：肝硬化中的质子泵抑制剂：病态状况的标志物还是死亡原因？
Hepatology. 2019 Aug;70(2):761-762. doi: 10.1002/hep.30642.
8
[Not Available].[无可用内容]。
MMW Fortschr Med. 2017 Jun;159(12):36. doi: 10.1007/s15006-017-9840-x.
9
Changes in the Microbiome in Cirrhosis and Relationship to Complications: Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, and Sepsis.肝硬化患者微生物组的变化及其与并发症的关系：肝性脑病、自发性细菌性腹膜炎和脓毒症
Semin Liver Dis. 2016 Sep;36(4):327-330. doi: 10.1055/s-0036-1593881. Epub 2016 Dec 20.
10
Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.质子泵抑制剂作为肝硬化伴腹水患者肝性脑病和自发性细菌性腹膜炎的危险因素。
Hepatology. 2016 Oct;64(4):1265-72. doi: 10.1002/hep.28737. Epub 2016 Aug 24.

引用本文的文献

1
Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial.在考虑住院失代偿期肝硬化患者中使用质子泵抑制剂、感染、肝性脑病与死亡率之间的关联时，探究指征性潜在混杂因素：ATTIRE试验的事后分析
EClinicalMedicine. 2023 Apr 4;58:101924. doi: 10.1016/j.eclinm.2023.101924. eCollection 2023 Apr.
2
Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis.失代偿期肝硬化患者短期使用质子泵抑制剂与肝性脑病风险
J Clin Med. 2019 Jul 25;8(8):1108. doi: 10.3390/jcm8081108.
3
Current and future pharmacological therapies for managing cirrhosis and its complications.
管理肝硬化及其并发症的当前和未来药理学治疗方法。
World J Gastroenterol. 2019 Feb 28;25(8):888-908. doi: 10.3748/wjg.v25.i8.888.
4
Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis.质子泵抑制剂与肝硬化住院期间肝性脑病风险的关联
United European Gastroenterol J. 2018 Oct;6(8):1179-1187. doi: 10.1177/2050640618773564. Epub 2018 Apr 23.
5
Recent advances in hepatic encephalopathy.肝性脑病的最新进展
F1000Res. 2017 Sep 4;6:1637. doi: 10.12688/f1000research.11938.1. eCollection 2017.